Targeted remodeling of prokaryotic genomes using CRISPR-nickases
View Patent ↗The present invention relates to kits and methods of modifying the prokaryotic genome a Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas system that utilized one nicking Cas nuclease and crRNAs. The kid and methods delete or replace portions of the prokaryotic genome. In some embodiments, an entire gene or multiple genes may be deleted or replaced.
1. A method of editing a target sequence in a genome of a prokaryotic cell, the method comprising:
introducing a first nucleotide sequence encoding into the prokaryotic cell, a nicking nuclease, wherein the nicking nuclease is a Cas9 mutant;
introducing at least one second nucleotide sequence encoding two crRNAs into the prokaryotic cell, wherein each crRNA comprises at least one guide sequence complementary to a region of the target sequence of the prokaryotic genome, wherein the region of the target sequence of the prokaryotic genome is less than 100 nucleotides from a repeated sequence of the prokaryotic genome and is adjacent to a protospacer adjacent motif (PAM);
coexpressing the first nucleotide sequence and the at least one second nucleotide sequence in the prokaryotic cell to generate a transformed prokaryotic cell; and
culturing the transformed prokaryotic cell to remove the target sequence from the genome of the cultured prokaryotic cell, wherein the method generates only single-stranded breaks in genome of the prokaryotic cell.
2. The method of claim 1 , wherein at least one pair of crRNAs that comprise guide sequences complementary to the 5′ end and 3′ end of the target sequence is introduced into the prokaryotic cell, culturing the transformed prokaryote deletes the target sequence from the genome of the prokaryotic cell.
3. The method of claim 1 , further comprising introducing a third nucleotide sequence encoding a donor sequence, wherein the donor sequence comprises the repeated sequence of the prokaryotic genome, and a replacement sequence.
4. The method of claim 3 , wherein the coexpressing step further comprises coexpressing the third nucleotide sequence in the prokaryotic cell, culturing the transformed prokaryotic cell replaces the target sequence with the replacement sequence in the genome of the cultured prokaryotic cell.
5. The method of claim 1 , wherein the target sequence is less than 50 nucleotides from the repeated sequence or homologous sequence of the prokaryotic genome.
6. The method of claim 1 , wherein the target sequence is between 20 nucleotides to 40 nucleotides from the repeated sequence or homologous sequence of the prokaryotic genome.
7. The method of claim 1 , wherein the target sequence is 20 nucleotides from the repeated sequence or homologous sequence of the prokaryotic genome.
8. The method of claim 1 , wherein the crRNA is an sgRNA comprising an 18-22 nucleotide-long guide sequence.
9. The method of claim 1 , wherein the Cas9 mutant comprises either a mutation in its RuvCl nuclease domain or a mutation in its HNH nuclease domain.
10. The method of claim 9 , wherein the mutation is a D10A substitution.
11. The method of claim 9 , wherein the mutation is a H840A substitution.
12. The method of claim 1 , wherein 36 Kb to 97 Kb of the genome of the prokaryotic cell is deleted or replaced.
13. The method of claim 1 , wherein 36 Kb of the genome of the prokaryotic cell is deleted or replaced.
14. The method of claim 1 , wherein 97 Kb of the genome of the prokaryotic cell is deleted or replaced.
15. The method of claim 1 , wherein two crRNAs are introduced into the prokaryotic cell and each crRNA comprises one guide sequence.
16. The method of claim 1 , wherein the prokaryotic cell is Escherichia coli.